Literature DB >> 24547783

Monitoring nanoparticle-mediated cellular hyperthermia with a high-sensitivity biosensor.

Amarnath Mukherjee1, Mark Castanares, Mohammad Hedayati, Michele Wabler, Bruce Trock, Prakash Kulkarni, Ronald Rodriguez, Robert H Getzenberg, Theodore L DeWeese, Robert Ivkov, Shawn E Lupold.   

Abstract

AIM: To develop and apply a heat-responsive and secreted reporter assay for comparing cellular response to nanoparticle (NP)- and macroscopic-mediated sublethal hyperthermia. MATERIALS &
METHODS: Reporter cells were heated by water bath (macroscopic heating) or iron oxide NPs activated by alternating magnetic fields (nanoscopic heating). Cellular responses to these thermal stresses were measured in the conditioned media by secreted luciferase assay. RESULTS &
CONCLUSION: Reporter activity was responsive to macroscopic and nanoparticle heating and activity correlated with measured macroscopic thermal dose. Significant cellular responses were observed with NP heating under doses that were insufficient to measurably change the temperature of the system. Under these conditions, the reporter response correlated with proximity to cells loaded with heated nanoparticles. These results suggest that NP and macroscopic hyperthermia may be distinctive under conditions of mild hyperthermia.

Entities:  

Keywords:  Metridia luciferase; heat shock; hyperthermia; iron oxide nanoparticle; nanoparticle

Mesh:

Substances:

Year:  2014        PMID: 24547783      PMCID: PMC4136989          DOI: 10.2217/nnm.13.207

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  33 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  A future for hyperthermia in cancer treatment?

Authors:  O S Nielsen; M Horsman; J Overgaard
Journal:  Eur J Cancer       Date:  2001-09       Impact factor: 9.162

Review 3.  Theranostic applications of nanoparticles in cancer.

Authors:  Naveed Ahmed; Hatem Fessi; Abdelhamid Elaissari
Journal:  Drug Discov Today       Date:  2012-03-30       Impact factor: 7.851

4.  The relationship between heating time and temperature: its relevance to clinical hyperthermia.

Authors:  S B Field; C C Morris
Journal:  Radiother Oncol       Date:  1983-11       Impact factor: 6.280

5.  A regulatory upstream promoter element in the Drosophila hsp 70 heat-shock gene.

Authors:  H R Pelham
Journal:  Cell       Date:  1982-09       Impact factor: 41.582

6.  Intracellular hyperthermia. A biophysical approach to cancer treatment via intracellular temperature and biophysical alterations.

Authors:  R T Gordon; J R Hines; D Gordon
Journal:  Med Hypotheses       Date:  1979-01       Impact factor: 1.538

7.  Time-temperature relationship th hyperthermic treatment of malignant and normal tissue in vivo.

Authors:  J Overgaard; H D Suit
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

8.  Human HSP70 promoter contains at least two distinct regulatory domains.

Authors:  B J Wu; R E Kingston; R I Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

9.  The effect of cell cluster size on intracellular nanoparticle-mediated hyperthermia: is it possible to treat microscopic tumors?

Authors:  Mohammad Hedayati; Owen Thomas; Budri Abubaker-Sharif; Haoming Zhou; Christine Cornejo; Yonggang Zhang; Michele Wabler; Jana Mihalic; Cordula Gruettner; Fritz Westphal; Alison Geyh; Theodore L Deweese; Robert Ivkov
Journal:  Nanomedicine (Lond)       Date:  2012-11-22       Impact factor: 5.307

10.  Identification of common gene networks responsive to mild hyperthermia in human cancer cells.

Authors:  Ayako Kariya; Yoshiaki Tabuchi; Tatsuya Yunoki; Takashi Kondo
Journal:  Int J Mol Med       Date:  2013-04-30       Impact factor: 4.101

View more
  1 in total

Review 1.  Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.

Authors:  Frederik Soetaert; Preethi Korangath; David Serantes; Steven Fiering; Robert Ivkov
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.